Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Oct 24, 2026 | Capital Blue Cross | General Inflammation Testing | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Gamma-glutamyl Transferase Testing in Adults | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Folate Testing | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Flow Cytometry | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Fecal Calprotectin Testing in Adults | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Evaluation of Dry Eyes | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Epithelial Cell Cytology in Breast Cancer Risk Assessment | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Diagnostic Testing of Iron Homeostasis and Metabolism | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Diagnostic Testing of Influenza | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Diagnosis of Vaginitis | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Diagnosis of Idiopathic Environmental Intolerance | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Diabetes Mellitus Testing | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Coronavirus Testing in the Outpatient Setting | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Celiac Disease Testing | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Cardiovascular Disease Risk Assessment | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Bone Turnover Markers Testing | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Biomarker Testing for Autoimmune Rheumatic Disease | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Biomarkers for Myocardial Infarction and Chronic Heart Failure | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | β-Hemolytic Streptococcus Testing | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Photocoagulation Therapy for Treatment of AMD | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Vagus Nerve Blocking Therapy for the Treatment of Obesity | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Spinal Cord and Dorsal Root Ganglion Stimulation | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Intravenous Antibiotic Therapy for Lyme Disease | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Interventions for Progressive Scoliosis | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Implantable Infusion Pumps for Pain and Spasticity | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Viral Tropism Testing | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Therapeutic Radiopharmaceuticals for Neuroendocrine Tumors | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Parenteral Nutrition | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Clinical Trials | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Zoledronic Acid (Reclast, Zometa) | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Ultrasonographic Measurement of Carotid Intimal Medial Thickness as an Assessment of Subclinical Atherosclerosis | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Ultrafiltration in Decompensated Heart Failure | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Treatment of Tinnitus | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Treatment of Menieres and Sudden Hearing Loss | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Treatment for Duchenne Muscular Dystrophy | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Transcatheter Pulmonary Valve Implantation | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Transcatheter Mitral Valve Procedures | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Transcatheter Aortic Valve Implantation for Aortic Stenosis | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Telestroke | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | T-Wave Alternans Testing | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Suprachoroidal Delivery of Pharmacologic Agents | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Speech Generating Devices | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Retinal Telescreening for Diabetic Retinopathy | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Retinal Prosthesis | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Quantitative Electroencephalography as a Diagnostic Aid for Attention Deficit-Hyperactivity Disorder | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Prosthetics and Accessories | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Procedures of Questionable Current Usefulness | Metadata changed |
| Oct 24, 2026 | Capital Blue Cross | Procedures Completed in an Ambulatory Surgery Center Using General or Regional Anesthesia | Metadata changed |